October 6 University

o6u.edu.eg

Total trials

129

Active

22

Phase 3

5

Total enrollment

7,462

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 10 of 10 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Metformin Hydrochloride1
Vildagliptin 50 MG1
Prednisolone1
Cerebrolysin1
Fexofenadine1
Montelukast 10 Mg Oral1
P11-4, a self-assembling peptide1
P11-4, a self-assembling peptide with flouride1
resin infilteration1
Chitosan Phonophresis1

Next readouts

  • 2024-09-30
  • 2025-02
  • 2025-12
  • 2025-12-01
  • 2026-01
  • 2027-05

Top conditions

  • Stroke8
  • Low Back Pain4
  • Carpal Tunnel Syndrome3
  • Cervical Radiculopathy3
  • Rehabilitation3
  • Oral Lichen Planus2
  • Gingival Recession2
  • Fibromyalgia2

Frequently asked questions about October 6 University

How many clinical trials does October 6 University have on ClinicalTrials.gov?
October 6 University is listed as the lead sponsor on 129 clinical trials in ClinicalTrials.gov, 22 of which are currently active (recruiting, enrolling, or ongoing).
How many of October 6 University's trials are in Phase 3?
5 of October 6 University's trials are in Phase 3, spread across 10 active drug programs.
What therapeutic areas does October 6 University focus on?
October 6 University's most-studied conditions on ClinicalTrials.gov are Stroke, Low Back Pain, Carpal Tunnel Syndrome, Cervical Radiculopathy, Rehabilitation.
When are October 6 University's next clinical trial readouts?
October 6 University has 6 upcoming primary-completion readouts tracked here; the soonest is “Chitosan Phonophresis on Cervical IN Smartphone Addicted Users”, expected around 2024-09-30.